Literature DB >> 16580760

Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam.

Vu Dinh Thiem1, Jacqueline L Deen, Lorenz von Seidlein, Do Gia Canh, Dang Duc Anh, Jin-Kyung Park, Mohammad Ali, M Carolina Danovaro-Holliday, Nguyen Dinh Son, Nguyen Thai Hoa, Jan Holmgren, John D Clemens.   

Abstract

We assessed the long-term protection afforded by a killed whole-cell oral cholera vaccine produced in Vietnam. A mass immunization of children and adults with the killed whole-cell oral cholera vaccine was undertaken in half of the communes of Hue, Vietnam, in 1998; the remaining communes were immunized in 2000. No cholera was observed in Hue until 2003, when an outbreak of El Tor cholera made it possible to conduct a case-control study. The overall vaccine effectiveness 3-5 years after vaccination was 50% (9-63%). This low-cost, easily administered vaccine should be considered as a tool for the control of cholera.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580760     DOI: 10.1016/j.vaccine.2006.03.008

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  25 in total

1.  Cholera: lessons from haiti and beyond.

Authors:  Ana A Weil; Louise C Ivers; Jason B Harris
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

Review 2.  New-generation vaccines against cholera.

Authors:  John Clemens; Sunheang Shin; Dipika Sur; G Balakrish Nair; Jan Holmgren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-08       Impact factor: 46.802

Review 3.  Killed oral cholera vaccines: history, development and implementation challenges.

Authors:  Anna Lena Lopez; Maria Liza Antoinette Gonzales; Josephine G Aldaba; G Balakrish Nair
Journal:  Ther Adv Vaccines       Date:  2014-09

Review 4.  Cholera.

Authors:  Jason B Harris; Regina C LaRocque; Firdausi Qadri; Edward T Ryan; Stephen B Calderwood
Journal:  Lancet       Date:  2012-06-30       Impact factor: 79.321

5.  Comparison of two control groups for estimation of oral cholera vaccine effectiveness using a case-control study design.

Authors:  Molly F Franke; J Gregory Jerome; Wilfredo R Matias; Ralph Ternier; Isabelle J Hilaire; Jason B Harris; Louise C Ivers
Journal:  Vaccine       Date:  2017-09-12       Impact factor: 3.641

6.  Transmission dynamics and control of cholera in Haiti: an epidemic model.

Authors:  Jason R Andrews; Sanjay Basu
Journal:  Lancet       Date:  2011-03-15       Impact factor: 79.321

Review 7.  Vibrio cholerae: lessons for mucosal vaccine design.

Authors:  Anne L Bishop; Andrew Camilli
Journal:  Expert Rev Vaccines       Date:  2011-01       Impact factor: 5.217

8.  Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit.

Authors:  Gi-eun Rhie; Hae-Mi Jung; Bong Su Kim; John J Mekalanos
Journal:  Vaccine       Date:  2008-06-26       Impact factor: 3.641

9.  Use of oral cholera vaccine in complex emergencies: what next? Summary report of an expert meeting and recommendations of WHO.

Authors:  Claire-Lise Chaignat; Victoria Monti
Journal:  J Health Popul Nutr       Date:  2007-06       Impact factor: 2.000

10.  Cholera in Haiti: reproductive numbers and vaccination coverage estimates.

Authors:  Zindoga Mukandavire; David L Smith; J Glenn Morris
Journal:  Sci Rep       Date:  2013-01-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.